SFX by Ex Libris Inc.

Users interested in this article also expressed an interest in the following:

description	1.	Baba, T W W. "Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection." Nature medicine 6.2 (2000): 200-6.
description	2.	Trkola, A. "Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies." Nature medicine 11.6 (2005): 615-22.
description	3.	Montefiori, David C. "Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?" Current opinion in HIV and AIDS 4.5 (2009): 347-351.
description	4.	Njai, H F. "P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections." Retrovirology 6.Suppl 3 (2009).
description	5.	Mofenson, Lynne M. "Antiretroviral drugs to prevent breastfeeding HIV transmission." Antiviral therapy 15.4 (2010): 537-553.
description	6.	Guay, L. "Decreasing HIV transmission through breastfeeding: Moving from evidence to practice." Journal of acquired immune deficiency syndromes 57.4 (2011): 258-260.
description	7.	Montefiori, D. "Neutralizing antibodies take a swipe at HIV in vivo." Nature medicine 11.6 (2005): 593-594.
description	8.	IMpact-RSV_Study_Group, D. "Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants." Pediatrics 102.3 (1998): 531-7.
description	9.	Walls, T. "Breastfeeding in mothers with HIV." Journal of paediatrics and child health 46.6 (2010): 349-352.
description	10.	Coovadia, H. "Current issues in prevention of mother-to-child transmission of HIV-1." Current opinion in HIV and AIDS 4.4 (2009): 319-324.
description	11.	Tonks, A. "HIV vaccines must do better than nature." British Medical Journal; International edition; BMJ 337.7670 (2008): 601-.
description	12.	Montefiori, Guido C. "Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination." Current opinion in HIV and AIDS 2.3 (2007): 169-176.
description	13.	Mascola, John R R. "Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1." Vaccine 20.15 (2002): 1922-5.
description	14.	Girard, Marc P P. "A review of vaccine research and development: the human immunodeficiency virus (HIV)." Vaccine 24.19 (2006): 4062-81.
description	15.	Papadea, C. "Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects." Critical reviews in clinical laboratory sciences 27.1 (1989): 27-58.
description	16.	Stoiber, H. "Complement, Fc receptors and antibodies: a Trojan horse in HIV infection?" Current opinion in HIV and AIDS 4.5 (2009): 394-399.
description	17.	Forsell, Mattias N E N. "Immunogenicity of HIV-1 envelope glycoprotein oligomers." Current opinion in HIV and AIDS 4.5 (2009): 380-387.
description	18.	Coetzer, M. "Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa." AIDS research and human retroviruses 23.2 (2007): 316-21.
description	19.	Goldschmidt, V. "Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs)." The international journal of biochemistry & cell biology 36.9 (2004): 1687-705.
description	20.	Featherstone, J D B D. "Clinical trial of a plant-derived antibody on recolonization of mutans streptococci." Caries research 39.3 (2005): 241-50.

View More...

View Less...

Select All Clear All Save Citations Select Format Reference Manager EndNote ProCite